{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:18:50Z","timestamp":1790731130528,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00595-019-01856-z","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T14:05:19Z","timestamp":1564495519000},"page":"171-177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Surgical management for peritoneal carcinomatosis of appendiceal origin with a high-tumor burden"],"prefix":"10.1007","volume":"50","author":[{"given":"Toshiyuki","family":"Kitai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenya","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Inamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,30]]},"reference":[{"key":"1856_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","volume":"7","author":"PH Sugarbaker","year":"2006","unstructured":"Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol. 2006;7:69\u2013766.","journal-title":"Lancet Oncol."},{"key":"1856_CR2","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737\u201343.","journal-title":"J Clin Oncol."},{"key":"1856_CR3","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.ejso.2016.03.016","volume":"42","author":"Y Yonemura","year":"2016","unstructured":"Yonemura Y, Canbay E, Li Y, Coccolini F, Glehen O, Sugarbaker PH, et al. A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent. Eur J Surg Oncol. 2016;42:1123\u201331.","journal-title":"Eur J Surg Oncol."},{"key":"1856_CR4","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1245\/s10434-015-4387-5","volume":"22","author":"D Go\u00e9r\u00e9","year":"2015","unstructured":"Go\u00e9r\u00e9 D, Souadka A, Faron M, Cloutier AS, Viana B, Honor\u00e9 C, et al. Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study. Ann Surg Oncol. 2015;22:2958\u201364.","journal-title":"Ann Surg Oncol."},{"key":"1856_CR5","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"TC Chua","year":"2012","unstructured":"Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30:2449\u2013566.","journal-title":"J Clin Oncol."},{"key":"1856_CR6","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.1002\/cncr.25356","volume":"116","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Boutitie F, Bereder JM, Quenet F, Sideris L, et al. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer. 2010;116:5608\u201318.","journal-title":"Cancer"},{"key":"1856_CR7","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1245\/s10434-009-0875-9","volume":"17","author":"A Saxena","year":"2010","unstructured":"Saxena A, Yan TD, Chua TC, Morris DL. Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol. 2010;17:1291\u2013301.","journal-title":"Ann Surg Oncol."},{"key":"1856_CR8","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1245\/s10434-017-6315-3","volume":"25","author":"KI Votanopoulos","year":"2018","unstructured":"Votanopoulos KI, Bartlett D, Moran B, Haroon CM, Russell G, Pingpank JF, et al. PCI is not predictive of survival after complete CRS\/HIPEC in peritoneal dissemination from high-grade appendiceal primaries. Ann Surg Oncol. 2018;25:674\u20138.","journal-title":"Ann Surg Oncol."},{"key":"1856_CR9","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1245\/s10434-015-4838-z","volume":"23","author":"PM Polanco","year":"2016","unstructured":"Polanco PM, Ding Y, Knox JM, Ramalingam L, Jones H, Hogg ME, et al. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion in patients with high-grade, high-volume disseminated mucinous appendiceal neoplasms. Ann Surg Oncol. 2016;23:382\u201390.","journal-title":"Ann Surg Oncol."},{"key":"1856_CR10","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1245\/s10434-014-3869-1","volume":"21","author":"W Jimenez","year":"2014","unstructured":"Jimenez W, Sardi A, Nieroda C, Sittig M, Milovanov V, Nunez M, et al. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2014;21:4218\u201325.","journal-title":"Ann Surg Oncol."},{"key":"1856_CR11","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ejso.2010.01.006","volume":"36","author":"D Elias","year":"2010","unstructured":"Elias D, Gilly F, Quenet F, Bereder JM, Sid\u00e9ris L, Mansvelt B, et al. Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol. 2010;36:456\u201362.","journal-title":"Eur J Surg Oncol."},{"key":"1856_CR12","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ejso.2016.01.015","volume":"42","author":"L Benhaim","year":"2016","unstructured":"Benhaim L, Honor\u00e9 C, Go\u00e9r\u00e9 D, Delhorme JB, Elias D. Huge pseudomyxoma peritonei: surgical strategies and procedures to employ to optimize the rate of complete cytoreductive surgery. Eur J Surg Oncol. 2016;42:552\u20137.","journal-title":"Eur J Surg Oncol."},{"key":"1856_CR13","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1245\/s10434-015-4446-y","volume":"22","author":"SP Dineen","year":"2015","unstructured":"Dineen SP, Royal RE, Hughes MS, Sagebiel T, Bhosale P, Overman M, et al. A simplified preoperative assessment predicts complete cytoreduction and outcomes in patients with low-grade mucinous adenocarcinoma of the appendix. Ann Surg Oncol. 2015;22:3640\u20136.","journal-title":"Ann Surg Oncol."},{"key":"1856_CR14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00384-011-1303-8","volume":"27","author":"TC Chua","year":"2012","unstructured":"Chua TC, Liauw W, Morris DL. Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome. Int J Colorectal Dis. 2012;27:381\u20139.","journal-title":"Int J Colorectal Dis"},{"key":"1856_CR15","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1245\/s10434-018-6336-6","volume":"25","author":"RM Dodson","year":"2018","unstructured":"Dodson RM, Kuncewitch M, Votanopoulos KI, Shen P, Levine EA. Techniques for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2018;25:2152\u20138.","journal-title":"Ann Surg Oncol."},{"key":"1856_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/jso.21054","volume":"98","author":"B Moran","year":"2008","unstructured":"Moran B, Baratti D, Yan TD, Kusamura S, Deraco M. Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasm with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol. 2008;98:277\u201382.","journal-title":"J Surg Oncol."},{"key":"1856_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","volume":"40","author":"NJ Carr","year":"2016","unstructured":"Carr NJ, Cecil TD, Mohamed F, Sobin LH, Sugarbaker PH, Gonz\u00e1lez-Moreno S, et al. A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the peritoneal surface oncology group international (PSOGI) modified Delphi process. Am J Surg Pathol. 2016;40:14\u201326.","journal-title":"Am J Surg Pathol"},{"key":"1856_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29\u2013422.","journal-title":"Ann Surg"},{"key":"1856_CR19","first-page":"29","volume":"7","author":"PH Sugarbaker","year":"2016","unstructured":"Sugarbaker PH, Van der Speeten K. Surgical technology and pharmacology of hyperthermic perioperative chemotherapy. J Gastrointest Oncol. 2016;7:29\u201344.","journal-title":"J Gastrointest Oncol"},{"key":"1856_CR20","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/bjs.9674","volume":"101","author":"S Kusamura","year":"2014","unstructured":"Kusamura S, Moran BJ, Sugarbaker PH, Levine EA, Elias D, Baratti D, et al. Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei. Br J Surg. 2014;101:1758\u201365.","journal-title":"Br J Surg"},{"key":"1856_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.suronc.2014.10.002","volume":"23","author":"LL Shan","year":"2014","unstructured":"Shan LL, Saxena A, Shan BL, Morris DL. Quality of life after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy for peritoneal carcinomatosis: a systematic review and meta-analysis. Surg Oncol. 2014;23:199\u201321010.","journal-title":"Surg Oncol"},{"key":"1856_CR22","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.ejso.2016.04.059","volume":"42","author":"Y Liu","year":"2016","unstructured":"Liu Y, Mizumoto A, Ishibashi H, Takeshita K, Hirano M, Ichinose M, et al. Should total gastrectomy and total colectomy be considered for selected patients with severe tumor burden of pseudomyxoma peritonei in cytoreductive surgery? Eur J Surg Oncol. 2016;42:1018\u201323.","journal-title":"Eur J Surg Oncol."},{"key":"1856_CR23","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s10147-016-1078-6","volume":"22","author":"T Kitai","year":"2017","unstructured":"Kitai T, Yamanaka K, Miyauchi Y, Kawashima M. Indications for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in elderly patients with peritoneal malignancy. Int J Clin Oncol. 2017;22:519\u201325.","journal-title":"Int J Clin Oncol."},{"key":"1856_CR24","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jamcollsurg.2011.02.002","volume":"212","author":"KP Raghav","year":"2011","unstructured":"Raghav KP, Taggart MW, Fournier KF, Overman MJ. Is malignant dedifferentiation for mucinous appendiceal neoplasms a valid phenomenon or merely histopathologic ambiguity? J Am Coll Surg. 2011;212:906.","journal-title":"J Am Coll Surg."},{"key":"1856_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ejso.2016.08.021","volume":"43","author":"JB Delhorme","year":"2017","unstructured":"Delhorme JB, Honor\u00e9 C, Benhaim L, Dumont F, Dartigues P, Dromain C, et al. Long-term survival after aggressive treatment of relapsed serosal or distant pseudomyxoma peritonei. Eur J Surg Oncol. 2017;43:159\u201367.","journal-title":"Eur J Surg Oncol."},{"key":"1856_CR26","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.ejso.2013.08.017","volume":"39","author":"A Sardi","year":"2013","unstructured":"Sardi A, Jimenez WA, Nieroda C, Sittig M, Macdonald R, Gushchin V. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes. Eur J Surg Oncol. 2013;39:1207\u201313.","journal-title":"Eur J Surg Oncol."},{"key":"1856_CR27","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s10147-017-1217-8","volume":"23","author":"T Kitai","year":"2018","unstructured":"Kitai T, Yamanaka K. Repeat cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal carcinomatosis of appendiceal origin. Int J Clin Oncol. 2018;23:298\u2013304.","journal-title":"Int J Clin Oncol"},{"key":"1856_CR28","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1245\/s10434-015-5019-9","volume":"23","author":"JB Delhorme","year":"2016","unstructured":"Delhorme JB, Elias D, Varatharajah S, Benhaim L, Dumont F, Honor\u00e9 C, et al. Can a benefit be expected from surgical debulking of unresectable pseudomyxoma peritonei? Ann Surg Oncol. 2016;23:1618\u201324.","journal-title":"Ann Surg Oncol."},{"key":"1856_CR29","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.ejso.2012.07.009","volume":"38","author":"H Andr\u00e9asson","year":"2012","unstructured":"Andr\u00e9asson H, Graf W, Nygren P, Glimelius B, Mahteme H. Outcome differences between debulking surgery and cytoreductive surgery in patients with Pseudomyxoma peritonei. Eur J Surg Oncol. 2012;38:962\u20138.","journal-title":"Eur J Surg Oncol."},{"key":"1856_CR30","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1245\/s10434-013-3053-z","volume":"20","author":"KI Votanopoulos","year":"2013","unstructured":"Votanopoulos KI, Newman NA, Russell G, Ihemelandu C, Shen P, Stewart JH, et al. Outcomes of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients older than 70 years; survival benefit at considerable morbidity and mortality. Ann Surg Oncol. 2013;20:3497\u2013503.","journal-title":"Ann Surg Oncol."},{"key":"1856_CR31","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/SLA.0b013e31825704e3","volume":"256","author":"D Baratti","year":"2012","unstructured":"Baratti D, Kusamura S, Mingrone E, Balestra MR, Laterza B, Deraco M. Identification of a subgroup of patients at highest risk for complications after surgical cytoreduction. Ann Surg. 2012;256:334\u201341.","journal-title":"Ann Surg."},{"key":"1856_CR32","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1097\/SLA.0000000000001593","volume":"263","author":"R Kwakman","year":"2016","unstructured":"Kwakman R, Schrama AM, van Olmen JP, Otten RH, de Lange-de Klerk ES, de Cuba EM, et al. Parameters in patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer metastases: a meta-analysis. Ann Surg. 2016;263:1102\u201311.","journal-title":"Ann Surg"},{"key":"1856_CR33","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.1245\/s10434-017-6111-0","volume":"24","author":"IT Konstantinidis","year":"2017","unstructured":"Konstantinidis IT, Chouliaras K, Levine EA, Lee B, Votanopoulos KI. Frailty correlates with postoperative mortality and major morbidity after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2017;24:3825\u201330.","journal-title":"Ann Surg Oncol."}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-019-01856-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00595-019-01856-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-019-01856-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T23:39:12Z","timestamp":1595979552000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00595-019-01856-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,30]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1856"],"URL":"https:\/\/doi.org\/10.1007\/s00595-019-01856-z","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,30]]},"assertion":[{"value":"10 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}